ECI Pharmaceuticals, LLC Receives FDA Warning Letter
Fort Lauderdale, Fla., May 10, 2021 – ECI Pharmaceuticals, LLC (ECI) today announced that it has entered into an exclusive U.S. agreement with Qilu Pharmaceutical Co., Ltd. (Qilu) to manage the sales, marketing, and distribution for the therapeutically equivalent generic of Cialis®, with strengths of 2.5mg, 5mg, 10mg, 20mg tablets. Cialis®, and the generic equivalent…
FORT LAUDERDALE, Fla., April 23, 2021 (GLOBE NEWSWIRE) — ECI Pharmaceuticals, LLC (ECI) today announced that it has entered into an exclusive U.S. distribution agreement with AiPing Pharmaceuticals, Inc. (AiPing) to manage the sales, marketing, and distribution of Ibuprofen 400 mg, 600 mg, 800 mg tablets, and Folic Acid 1 mg tablets. According to IQVIA…
ECI Pharmaceuticals LLC Enters into Exclusive U.S. Distribution Agreement for Ibuprofen
ECI Pharm`s Generic Chlordiazepoxide; Clidinium bromide Receives Approval in US
CHICAGO, July 1, 2020 /PRNewswire/ --Upadhye Cwik LLP prides itself as an innovative law firm that can provide efficient and effective legal representation to large and small pharmaceutical and device companies alike. Upadhye Cwik takes an integrative approach to problem solving, and is equally adapt in court, at the international trade commission (ITC), and at the FDA.